[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial...

BWAY : 14.98 (-6.49%)
HYFT : 1.5100 (-7.93%)
ICAD : 3.87 (+3.75%)
Cancer Surge Meets Funding Crunch as Breakthrough Biotechs Line Up Milestones in 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – More and more young women are getting diagnosed with cancer than ever before, causing many to sound the...

ONCY : 0.8558 (-2.77%)
CTXR : 0.5835 (-3.95%)
CTOR : 0.7101 (+0.17%)
ONC.TO : 1.42 (+2.16%)
RDNT : 67.83 (-1.58%)
ICAD : 3.87 (+3.75%)
RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading suite of AI-powered breast cancer image interpretation...

RDNT : 67.83 (-1.58%)
ICAD : 3.87 (+3.75%)
iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.

ICAD : 3.87 (+3.75%)
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health

Issued on behalf of Avant Technologies Inc. Vancouver, BC – June 17, 2025 – USA News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...

MSFT : 388.84 (+0.54%)
AVAI : 0.1170 (-6.85%)
RXRX : 3.84 (-3.03%)
AMZN : 245.98 (+0.75%)
ICAD : 3.87 (+3.75%)
Capital Flows Shift From Research Labs to Pharmacy Counters—A Watershed Moment for AI Health

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...

MSFT : 388.84 (+0.54%)
AVAI : 0.1170 (-6.85%)
RXRX : 3.84 (-3.03%)
AMZN : 245.98 (+0.75%)
ICAD : 3.87 (+3.75%)
Icad: Q1 Earnings Snapshot

Icad: Q1 Earnings Snapshot

ICAD : 3.87 (+3.75%)
iCAD Reports Financial Results for First Quarter Ended March 31, 2025

ICAD : 3.87 (+3.75%)
Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators

/CNW/ -- USA News Group News Commentary – In a clear sign of growing confidence in artificial intelligence (AI) for healthcare, the U.S. Food and Drug...

MSFT : 388.84 (+0.54%)
AIDX.TO : 0.76 (-3.80%)
HWAIF : 0.5300 (-4.06%)
AVAI : 0.1170 (-6.85%)
RDNT : 67.83 (-1.58%)
ICAD : 3.87 (+3.75%)
Investors Are Watching Artificial Intelligence (AI) Reshape Diagnostics and Drug Discovery

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating....

MSFT : 388.84 (+0.54%)
AVAI : 0.1170 (-6.85%)
LNTH : 103.41 (+0.57%)
RDNT : 67.83 (-1.58%)
ICAD : 3.87 (+3.75%)

Barchart Exclusives

Super Micro Drops 35% in a Month. What’s Next for SMCI Stock in 2026.
Solid demand for AI infrastructure, a large order backlog, expanding enterprise exposure, and a compelling valuation make SMCI attractive. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.